The state of Florida currently has 80 active clinical trials seeking participants for Diabetes research studies. These trials are conducted in various cities, including Miami, Tampa, Jacksonville and Orlando.
Abscisic Acid Effects on Glucose Homeostasis and Insulin Sensitivity
NCT04722354
Recruiting
The purpose of this study is to determine the effects of oral abscisic acid (ABA) on glucose metabolism in subjects with defined prediabetes.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
07/21/2023
Locations: AdventHealth Translational Research Institute, Orlando, Florida
Conditions: Pre Diabetes
Register for Updates
REsearching Covid-19 Outcomes in Diabetes (RECODE)
NCT04805970
Recruiting
The purpose of this study is to observe any changes that may occur to certain organs following a confirmed diagnosis of COVID-19 in people with and without diabetes.
Gender:
All
Ages:
18 years and above
Trial Updated:
07/21/2023
Locations: AdventHealth Translational Research Institute, Orlando, Florida
Conditions: Covid19, Diabetes
Register for Updates
Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes
NCT05626712
Recruiting
The brief purpose of this research study is to learn about the safety and efficacy of intra-arterial administration of CELZ-201 in patients with newly diagnosed Type 1 Diabetes Mellitus (T1D).
Gender:
All
Ages:
Between 18 years and 35 years
Trial Updated:
07/12/2023
Locations: Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida
Conditions: Type 1 Diabetes, Diabetes Mellitus, Type 1
Register for Updates
Obesity and Uric Acid Stones Study
NCT04621929
Recruiting
The investigator proposes an 18 month, feasibility pilot study, randomizing obese and diabetic individuals with pure uric acid nephrolithiasis (UAN) or mixed calcium oxalate (CO) UAN to either phentermine/topiramate or a pragmatic control group who will remain on their standard medication regimen (citrate salts, allopurinol, diet, etc.).
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
06/09/2023
Locations: University of Florida, Gainesville, Florida
Conditions: Obesity, Uric Acid Stones, Type 2 Diabetes Mellitus in Obese, Pre-Diabetes
Register for Updates
EndoBarrier System Pivotal Trial(Rev E v2)
NCT04101669
Recruiting
A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Evaluating the EndoBarrier System for Glycemic Improvement in Patients with Inadequately Controlled Type 2 Diabetes and Obesity, the STEP-1 Study. A multi-center, double-blinded, randomized, sham-controlled trial to evaluate the safety and effectiveness of the EndoBarrier System plus moderate intensity lifestyle and dietary counseling compliant with 2019 ADA Standard of Care as compared to a sham control receiving moderate intensity... Read More
Gender:
All
Ages:
Between 30 years and 65 years
Trial Updated:
05/09/2023
Locations: University of Miami Hospital, Miami, Florida
Conditions: Diabetes type2, Obesity
Register for Updates
C-myc Biomarker Study for Diabetic Foot Ulcers
NCT04591691
Recruiting
This is a multi-center observational cohort study of patients with diabetic foot ulcers (DFU) to develop and validate potential tissue-based biomarkers that predict complete wound healing. Eligible and consented participants will begin standard of care treatment after collection of tissue specimens from the wound's edge. An additional tissue specimen is collected at 4 weeks if clinically indicated. Tissues will be tested for c-myc and phosphorylated glucocorticoid receptor (p-GR) levels using va... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/29/2023
Locations: University of Miami, Miami, Florida
Conditions: Diabetes, Diabetic Foot, Diabetic Foot Ulcer, Diabetic Wound
Register for Updates
Continuous Glucose Monitoring for Hyperglycemia in Critically Ill Patients
NCT05442853
Recruiting
The investigators intend to conduct a single-center, prospective, randomized comparative trial of patients admitted to the intensive care unit (ICU) who received continuous glucose monitoring (CGM) vs point of care (POC) glucose monitoring. The study will examine relevant outcomes for patients in the ICU with diabetes mellitus and/or hyperglycemia. The primary outcome of the study will be the proportion of time in target range (blood glucose 70-180 mg/dL).
Gender:
All
Ages:
Between 18 years and 89 years
Trial Updated:
03/13/2023
Locations: North Florida/South Georgia Veterans Health System, Gainesville, Florida
Conditions: Hyperglycemia, Hypoglycemia, Critical Illness, Diabetes Mellitus
Register for Updates
Continuous Monitoring and Control of Hypoglycemia
NCT03340831
Recruiting
Evaluate safety of non-adjunctive CGM use in CGM naive participants.
Gender:
All
Ages:
2 years and above
Trial Updated:
09/17/2021
Locations: University of Florida Pediatric Endocrinology, Gainesville, Florida +2 locations
Conditions: Diabetes
Register for Updates